DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER
DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER
批准号:
9186150
负责人:
Obi L. Griffith
金额:
$30.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-20 至 2019-06-30
关键词:
AddressAffectBiological AssayClinicalClinical TrialsCommunitiesCompanionsComputer softwareConsensusConsultationsControlled VocabularyCustomDNA Sequence AlterationDataData ElementDatabasesDevelopmentDiseaseDocumentationEffectivenessEpigenetic ProcessEquilibriumFoundationsFreezingGene TargetingGenerationsGenesGenomeGenomicsGoalsHealthHumanImageryInternetKnowledgeLevel of EvidenceLicensingLiteratureMalignant NeoplasmsMapsMutationNotificationNucleotidesOntologyPharmaceutical PreparationsPublicationsRNAReagentRecurrenceReportingResearchResearch PersonnelResource InformaticsResourcesSchemeScientistSoftware ToolsSpecific qualifier valueStructureSystemTargeted ResearchTertiary Protein StructureUpdateVariantVocabularyabstractingactionable mutationanticancer researchapplication programming interfacecancer subtypesclinical applicationclinical decision-makingclinically actionableclinically significantcrowdsourcingdata miningdata modelingdesigngenetic variantimprovedindividual patientinterdisciplinary approachknowledge basemeetingsneoplasm resourceprecision medicineprecision oncologyprogramsprototyperesearch studysequencing platformsocial mediastemsymposiumtargeted sequencingtumortumor progressionusabilityuser-friendlyweb interfaceworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Clinical cancer sequencing will increasingly be used to identify genomic alterations that are relevant to
understanding cancer progression and improving clinical decision making for individual patients. Currently, the
most critical bottleneck in the precision medicine workflow is at the interpretation step. However, there are few
resources to help with the prioritization and interpretation of these alterations in a clinical context. Multiple
groups are building their own databases documenting clinical interpretation of tumor mutations as they are
observed in those groups. This represents a largely redundant effort with no mechanisms for capturing
evolving evidence from the biomedical literature. Public knowledgebases are needed with sophisticated
application programming interfaces (APIs) that allow rapid intersection of genomic alterations with
interpretations of their clinical actionability. The goal of this proposal is to develop such an expert-curated
knowledgebase, web interface and API for Clinical Interpretation of Variants in Cancer (CIViC -
www.civicdb.org). The knowledge created from this effort will be freely available and the product of open
discussion across a diverse community. This will require an interdisciplinary approach to combine the expertise
of genome scientists and cancer researchers, whose efforts are otherwise often isolated. Content will be
created with transparency, kept current, be comprehensive, track provenance, and acknowledge the efforts of
creators. It will cover all types of alterations from single nucleotide variants to structural variants, RNA fusions,
expression changes, epigenetic alterations and others. The interface will capture both structured statements of
evidence for actionability to allow computational data mining and also human-readable interpretations. Content
and software will be unencumbered and easy to access to encourage both academic and commercial
engagement. In order to achieve these goals CIViC will require well-designed data standards, use of structured
vocabularies, and a user-friendly curation interface that balances data mining needs with human accessibility.
Focused `hackathons' and curation meetings will be organized to establish community standards and
coordinate with synergistic efforts by the Global Alliance for Genomics and Health (GA4GH) and ClinGen
working groups. The CIViC resource will serve as the foundation for development of applications critical to
widespread implementation of precision medicine for cancer. Specifically, it will facilitate rapid generation of
targeted sequencing assays, automated clinical report generation, and other applications built upon the open
CIViC standards and APIs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine
-
批准号:10228464
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2019
-
负责人:Obi L. Griffith
-
依托单位:
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine
-
批准号:9905505
-
项目类别:
-
资助金额:$73.06万
-
财政年份:2019
-
负责人:Obi L. Griffith
-
依托单位:
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine
-
批准号:10370336
-
项目类别:
-
资助金额:$71.94万
-
财政年份:2019
-
负责人:Obi L. Griffith
-
依托单位:
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision Medicine
-
批准号:10620674
-
项目类别:
-
资助金额:$71.42万
-
财政年份:2019
-
负责人:Obi L. Griffith
-
依托单位:
DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCER
-
批准号:9319235
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2016
-
负责人:Obi L. Griffith
-
依托单位:
DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCER
-
批准号:8925830
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2014
-
负责人:Obi L. Griffith
-
依托单位:
DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCER
-
批准号:9124856
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2014
-
负责人:Obi L. Griffith
-
依托单位:
DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCER
-
批准号:8767892
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2014
-
负责人:Obi L. Griffith
-
依托单位:
海外基金